Teva Pharmaceutical Industries (NYSE:TEVA) just landed U.S. FDA approval for UZEDY, an extended-release injectable developed ...
Analysts have recently revised their consensus price target for lululemon athletica, decreasing it slightly from $198.36 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback